Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil

被引:48
作者
Chu, L. [1 ]
Gu, J. [1 ]
Sun, L. [1 ]
Qian, Q. [2 ]
Qian, C. [2 ]
Liu, X. [1 ,2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China
[2] Zhejiang Sci Tech Univ, Xinyuan Inst Med & Biotechnol, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
oncolytic adenovirus; short hairpin RNA; Apollon; cancer therapy; 5-fluorouracil;
D O I
10.1038/gt.2008.6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apollon, a membrane-associated inhibitor of apoptosis protein, protects cells against apoptosis and is upregulated in certain tumor cells. In this study, the effects of Apollon protein knockdown by RNA interference on the growth of human HeLa, HT-1080 and MCF-7 cells in vitro and in vivo were investigated. An oncolytic adenovirus (ZD55) containing the RNA polymerase III-dependent U6 promoter to express short hairpin RNA (shRNA) directed against Apollon (ZD55-siApollon) was constructed. Our data show that ZD55-siApollon successfully exerts a gene knockdown effect and causes the inhibition of tumor cell growth both in culture and in athymic mice in vivo. Cell cycle analysis, 4',6-diamidino-2-phenylindole staining and western blot analysis reveal that ZD55-siApollon-mediated suppression of Apollon induces apoptosis. Intratumoral injection of ZD55-siApollon significantly inhibits tumor growth in HT-1080 xenograft mice. Furthermore, ZD55-siApollon enhances the antitumor effect of 5-fluorouracil, a chemotherapeutic agent. In conclusion, these results suggest that the depletion of Apollon by oncolytic adenovirus-shRNA delivery system provides a promising method for cancer therapy.
引用
收藏
页码:484 / 494
页数:11
相关论文
共 39 条
[1]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[2]   Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase [J].
Bartke, T ;
Pohl, C ;
Pyrowolakis, G ;
Jentsch, S .
MOLECULAR CELL, 2004, 14 (06) :801-811
[3]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[4]   Conditionally replicating adenoviruses expressing short hairpin RNAs silence the expression of a target gene in cancer cells [J].
Carette, JE ;
Overmeer, RM ;
Schagen, FHE ;
Alemany, R ;
Barski, OA ;
Gerritsen, WR ;
van Beusechem, VW .
CANCER RESEARCH, 2004, 64 (08) :2663-2667
[5]   A human IAP-family gene, Apollon, expressed in human brain cancer cells [J].
Chen, ZH ;
Naito, M ;
Hori, S ;
Mashima, T ;
Yamori, T ;
Tsuruo, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (03) :847-854
[6]   Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-κB survival signaling in hepatocellular carcinoma [J].
Chu, Liang ;
Gu, Jinfa ;
He, Zhongniu ;
Xiao, Tian ;
Liu, Xinyuan .
CANCER BIOLOGY & THERAPY, 2006, 5 (06) :615-622
[7]   Inducible shRNA expression for application in a prostate cancer mouse model [J].
Czauderna, F ;
Santel, A ;
Hinz, M ;
Fechtner, M ;
Durieux, B ;
Fisch, G ;
Leenders, F ;
Arnold, W ;
Giese, K ;
Klippel, A ;
Kaufmann, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (21) :e127
[8]   A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors [J].
Duckett, CS ;
Nava, VE ;
Gedrich, RW ;
Clem, RJ ;
VanDongen, JL ;
Gilfillan, MC ;
Shiels, H ;
Hardwick, JM ;
Thompson, CB .
EMBO JOURNAL, 1996, 15 (11) :2685-2694
[9]   The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides [J].
Far, RKK ;
Sczakiel, G .
NUCLEIC ACIDS RESEARCH, 2003, 31 (15) :4417-4424
[10]   Cell death inhibition: Keeping caspases in check [J].
Goyal, L .
CELL, 2001, 104 (06) :805-808